Viewing Study NCT01022112

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT01022112
Status: COMPLETED
Last Update Posted: 2014-06-05
First Post: 2009-11-29
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
Sponsor: Tanabe Pharma Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TA-7284 View
None JNJ-28431754 View
None Canagliflozin View
None Type 2 diabetes mellitus View
None Sodium Glucose Co-transporter (SGLT2 inhibitor) View